Komori
Fuji Pharma (4554) · InitiativeRestated

Developing New DPC-Eligible Hospitals and Expanding Business

First written in FY2016-Q3. 7 of 8 entries say "Restated". Latest entry: FY2018-Q3.

8entries
3years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016-Q3 – FY2018-Q32016: 120162017: 420172018: 32018
Same theme, other companies
Pharmaceutical sales development and business expansion targeting DPC hospitalsA theme 2 companies write about · 0 as a headwind · 2 as a tailwind

0 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2018-Q3RestatedAnnual report

    「We are also actively pursuing sales activities to develop new business and expand transactions with DPC-participating hospitals nationwide, focusing mainly on products such as 「フィルグラスチムBS注」.」

    Continuing sales activities focused on developing new business and expanding transactions with DPC-participating hospitals for products such as 「フィルグラスチムBS注」.
  2. FY2018-Q2RestatedAnnual report

    「We are also actively pursuing sales activities to develop new business and expand transactions with DPC-participating hospitals nationwide, focusing mainly on products such as 「フィルグラスチムBS注」.」

    Continuing sales activities focused on developing new business and expanding transactions with DPC-participating hospitals for products such as 「フィルグラスチムBS注」.
  3. FY2018-Q1RestatedAnnual report

    「We are also actively pursuing sales activities to develop new business and expand transactions with DPC-participating hospitals nationwide, focusing mainly on products such as 「フィルグラスチムBS注」.」

    Continuing sales activities to develop new business and expand transactions with DPC-participating hospitals.
  4. FY2017RestatedAnnual report

    「We are also actively pursuing sales activities to develop new business and expand transactions with DPC-participating hospitals nationwide, focusing mainly on products such as 「フィルグラスチムBS注」.」

    Continuing sales activities to develop new business and expand transactions with DPC-participating hospitals.
  5. FY2017-Q3RestatedAnnual report

    「We are also actively pursuing sales activities to develop new business and expand transactions with DPC-participating hospitals nationwide, focusing mainly on products such as 「フィルグラスチムBS注」.」

    Continuing sales activities to develop new business and expand transactions with DPC-participating hospitals.
  6. FY2017-Q2RestatedAnnual report

    「We are also actively pursuing sales activities to develop new business and expand transactions with DPC-participating hospitals nationwide, focusing mainly on products such as 「フィルグラスチムBS注」.」

    Continuing sales activities to develop new business and expand transactions with DPC-participating hospitals.
  7. FY2017-Q1RestatedAnnual report

    「We are actively pursuing sales initiatives to develop new business and expand transactions with DPC-participating hospitals nationwide, focusing mainly on products such as 「フィルグラスチムBS注」.」

    Continuing sales activities to develop new business and expand transactions with DPC-participating hospitals.
  8. FY2016-Q3First statedAnnual report

    「We are actively pursuing sales initiatives to develop new business and expand transactions with DPC-participating hospitals nationwide, focusing mainly on products such as 「フィルグラスチムBS注」.」

    Describes sales initiatives to develop new business and expand transactions with DPC-participating hospitals.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Fuji Pharma yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Developing New DPC-Eligible Hospitals and Expanding Business | Fuji Pharma Co.,Ltd. (4554) | Komori